Viewpoint: FDA animal gene-editing rules boost food waste, stifle US agriculture research

| | September 5, 2019
x x e
UC Davis geneticist Alison Van Eenennaam
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A proposed U.S. regulatory framework for how the FDA treats gene-edited livestock may do more than put U.S. livestock producers at a disadvantage globally. It already has proven to be a source of food waste.

Dr. Alison Van Eenennaam knows firsthand how the proposed framework under which U.S. researchers must operate — which regards gene-edited livestock as a new animal drug and thus subject to the FDA’s new drug approval process — is and will be a source of food waste on a major scale.

“Typically at the university, our milk and meat and eggs go into commerce. We sell our milk from the dairy to the creamery, we slaughter our animals and the meat goes in the food supply. That is part of what keeps the wheels running at the research establishment,” Van Eenennaam said.

Related article:  ‘Sputnik 2.0’: China wants to lead the world in CRISPR research

Read full, original article: U.S. approval process for gene-edited livestock may hamper research

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend